These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10751117)

  • 1. Cytarabine and highly active antiretroviral therapy in HIV-related progressive multifocal leukoencephalopathy.
    Enting RH; Portegies P
    J Neurol; 2000 Feb; 247(2):134-8. PubMed ID: 10751117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.
    Hall CD; Dafni U; Simpson D; Clifford D; Wetherill PE; Cohen B; McArthur J; Hollander H; Yainnoutsos C; Major E; Millar L; Timpone J
    N Engl J Med; 1998 May; 338(19):1345-51. PubMed ID: 9571254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Albrecht H; Hoffmann C; Degen O; Stoehr A; Plettenberg A; Mertenskötter T; Eggers C; Stellbrink HJ
    AIDS; 1998 Jul; 12(10):1149-54. PubMed ID: 9677163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.
    De Luca A; Giancola ML; Ammassari A; Grisetti S; Cingolani A; Paglia MG; Govoni A; Murri R; Testa L; Monforte AD; Antinori A
    AIDS; 2000 Sep; 14(14):F117-21. PubMed ID: 11061646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Profile and Outcome of Progressive Multifocal Leukoencephalopathy in HIV Infected Indian Patients.
    Shah V; Toshniwal H; Shevkani M
    J Assoc Physicians India; 2017 Mar; 65(3):40-44. PubMed ID: 28462542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytarabine therapy for progressive multifocal leukoencephalopathy in patients with AIDS.
    Moreno S; Miralles P; Díaz MD; Berenguer J; Bernaldo de Quirós JC; Blázquez R; Cosín J; Bouza E
    Clin Infect Dis; 1996 Nov; 23(5):1066-8. PubMed ID: 8922804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Canadian PML Study Group.
    Fong IW; Toma E
    Clin Infect Dis; 1995 May; 20(5):1305-10. PubMed ID: 7620015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy (PML).
    Proj Inf Perspect; 1998 Apr; (24):23-4. PubMed ID: 11365717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy.
    Miralles P; Berenguer J; Lacruz C; Cosín J; López JC; Padilla B; Muñoz L; García-de-Viedma D
    AIDS; 2001 Sep; 15(14):1900-2. PubMed ID: 11579261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy.
    De Luca A; Giancola ML; Cingolani A; Ammassari A; Gillini L; Murri R; Antinori A
    Clin Infect Dis; 1999 Mar; 28(3):624-8. PubMed ID: 10194089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy.
    Miralles P; Berenguer J; García de Viedma D; Padilla B; Cosin J; López-Bernaldo de Quirós JC; Muñoz L; Moreno S; Bouza E
    AIDS; 1998 Dec; 12(18):2467-72. PubMed ID: 9875585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.
    Giancola ML; Rizzi EB; Lorenzini P; Rovighi L; Baldini F; Schininà V; Larussa D; Bibbolino C; Antinori A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):155-62. PubMed ID: 18240958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
    Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
    J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-cART progressive multifocal leukoencephalopathy era in a Brazilian center.
    Lima MA; Silva MTT; Afonso LA; Vaz BJP
    J Neurol Sci; 2017 Oct; 381():321-324. PubMed ID: 28991708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study.
    Falcó V; Olmo M; del Saz SV; Guelar A; Santos JR; Gutiérrez M; Colomer D; Deig E; Mateo G; Montero M; Pedrol E; Podzamczer D; Domingo P; Llibre JM
    J Acquir Immune Defic Syndr; 2008 Sep; 49(1):26-31. PubMed ID: 18667930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.
    Gasnault J; Taoufik Y; Goujard C; Kousignian P; Abbed K; Boue F; Dussaix E; Delfraissy JF
    J Neurovirol; 1999 Aug; 5(4):421-9. PubMed ID: 10463864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?].
    Montes Santiago J; Pérez Fernández E; González Vázquez L; Morano Amado L; Fernández Martín J; Asorey Carballeira A; Pérez Alvarez R
    An Med Interna; 2002 May; 19(5):230-3. PubMed ID: 12107996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for progressive multifocal leukoencephalopathy in HIV-infected persons: current status and future directions.
    Loignon M; Toma E
    Expert Rev Anti Infect Ther; 2016; 14(2):177-91. PubMed ID: 26655489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
    Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
    Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
    Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.